Shopping Cart (0)
My Account

Shopping Cart
3 for 2 Offer SELECTBIO Conferences Lab-on-a-Chip and Microfluidics Europe 2021Point-of-Care, Biosensors & Mobile Diagnostics Europe 20213D-Culture, Organoids & Organ-on-a-Chip Europe 2021The Space Summit 2021Flow Chemistry Summit 2021ePoster Award Prize

Extracellular Vesicles and Their Content as Biomarkers For Disease

Held in conjunction with Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2021

19 Oct 2021, at 19:30-22:00 in Rotterdam, The Netherlands


Extracellular Vesicles and Their Content as Biomarkers For Disease

This Training Course presents an overview and discussion of the current and potential applications of Extracellular Vesicles (EVs) as biomarkers of disease, especially in the context of cancer. An in-depth evaluation of EV isolation protocols suitable for biomarker discovery and application, and the bias these might introduce in the data, will be discussed. The impact of the quality of the disease samples on EV-based biomarkers will be an important point of consideration.

This course is designed for both the newcomers in the EV biomarker field as well as the experienced scientists who would like to share their perspectives and learn the up-to-date approaches.

Specific Topics Covered in this Training Course

  • Evaluating clinical unmet need for cancer biomarkers (Precision medicine)
  • Differences between tissue-relying and liquid-biopsy biomarkers
  • Introduction to using EVs (Exosomes and Microvesicles) as liquid biopsy cancer biomarkers
  • Isolation strategies for EVs, their advantages and disadvantages
  • Which EV components (RNA, Proteins, Lipids) are best suited as cancer biomarker
  • The different sources of EVs for use as biomarkers (liquid biopsies)
  • Quality considerations for test sample material
  • Transitioning lab-based EV isolation and biomarker tests to clinical applications
  • The role commercial partners can play in EV biomarker development and testing

All course attendees will receive electronic copies of the presentation as well as supplementary reviews, protocols used by my lab for EV isolation and other, suitable recent publications.

Who Should Attend

  • Researchers entering the field of EV-based liquid biopsy biomarkers
  • Established EV Researchers seeking to receive the most up-to-date information on EV cancer biomarker discovery and application
  • Companies seeking to provide tools and technologies for EV biomarkers and seek to understand the research landscape, unmet needs and opportunities
  • Companies involved in EV biomarker research seeking to understand the current research environment

Andreas Möller

Andreas Möller, Associate Professor, QIMR Berghofer Medical Research Institute